Sarilumab
Chemical compound
Sarilumab, sold under the brand name Kevzara, is a human monoclonal antibody medication against the interleukin-6 receptor. Regeneron Pharmaceuticals and Sanofi developed the drug for the treatment of rheumatoid arthritis (RA), for which it received US FDA approval on 22 May 2017 and European Medicines Agency approval on 23 June 2017.
Nº Q7424081 ★
Common · Knowledge
Sarilumab
Chemical compound
Sarilumab, sold under the brand name Kevzara, is a human monoclonal antibody medication against the interleukin-6 receptor. Regeneron Pharmaceuticals and Sanofi developed the drug for the treatment of rheumatoid arthritis (RA), for which it received US FDA approval on 22 May 2017 and European Medicines Agency approval on 23 June 2017.
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
Sarilumab, sold under the brand name Kevzara, is a human monoclonal antibody medication against the interleukin-6 receptor. Regeneron Pharmaceuticals and Sanofi developed the drug for the treatment of rheumatoid arthritis (RA), for which it received US FDA approval on 22 May 2017 and European Medicines Agency approval on 23 June 2017. Development in ankylosing spondylitis has been suspended after the drug failed to show clinical benefit over methotrexate in a phase II trial.
Text: Wikipédia, CC BY-SA 4.0. ·
Related cards
Interleukin 6
Mammalian protein found in Homo sapiens
Nº Q412889 ★★
Riamilovir
Chemical compound
Nº Q4462924 ★
Leronlimab
Monoclonal antibody against CCR5, for prevention of fusion of HIV with CCR5+ cells
Nº Q7120418 ★★
Colesevelam
Pharmaceutical drug
Nº Q899036 ★
Rituximab
Pharmaceutical drug
Nº Q412323 ★★★
Omalizumab
Pharmaceutical drug
Nº Q415392 ★★